Role of obesity in acute pancreatitis

doi:10.3877/cma.j.issn.1674-0785.2019.07.014

Abstract

Abstract:

The pancreas is an essential organ that has endocrine and exocrine function and plays a vital role in metabolism, digestion, and absorption. In recent years, as the number of obese people increases, the morbidity of obesity-related acute pancreatitis (AP) is increasing. However, the exact pathogenesis of obesity-related AP has not been fully elucidated. The research of obesity-related AP has gradually attracted wide attention. In this paper, we review the recent progress in research on the role of obesity in AP to help understand the pathogenesis and new therapeutic targets of AP.

Key words: Obesity, Pancreatitis, acute necrotizing, Fatty acids, unsaturated

Jiajun He, Meng Zhou, Yuanhao Li, Chuting Yang, Weiwei Chen, Jun Liu. Role of obesity in acute pancreatitis[J]. Chinese Journal of Clinicians(Electronic Edition), 2019, 13(07): 548-551.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhlcyszz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-0785.2019.07.014

https://zhlcyszz.cma-cmc.com.cn/EN/Y2019/V13/I07/548

References 43

[33]	Betzel B, Homan J, Aarts E, et al. Acute pancreatitis as an adverse event in patients with the duodenal-jejunal bypass liner [J]. Endoscopy, 2015, 47(11): 1050-1053.
[34]	Alsohaibani FI, Alkasab M, Abufarhaneh EH, et al. Acute pancreatitis as a complication of intragastric balloons: a case series [J]. Obes Surg, 2019, 29(5): 1694-1696.
[35]	Sadr-Azodi O, Orsini N, Andren-Sandberg A, et al. Abdominal and total adiposity and the risk of acute pancreatitis: a population-based prospective cohort study [J]. Am J Gastroenterol, 2013, 108(1): 133-139.
[36]	Navina S, Acharya C, DeLany JP, et al. Lipotoxicity causes multisystem organ failure and exacerbates acute pancreatitis in obesity [J]. Sci Transl Med, 2011, 3(107): 107-110.
[37]	Acharya C, Cline RA, Jaligama D, et al. Fibrosis reduces severity of acute-on-chronic pancreatitis in humans [J]. Gastroenterology, 2013, 145(2): 466-475.
[38]	Koutroumpakis E, Dasyam AK, Furlan A, et al. Isolated peripancreatic necrosis in acute pancreatitis is infrequent and leads to severe clinical course only when extensive: a prospective study from a us tertiary center [J]. J Clin Gastroenterol, 2016, 50(7): 589-595.
[39]	Mossner J, Bodeker H, Kimura W, et al. Isolated rat pancreatic acini as a model to study the potential role of lipase in the pathogenesis of acinar cell destruction [J]. Int J Pancreatol, 1992, 12(3): 285-296.
[40]	Noel P, Patel K, Durgampudi C, et al. Peripancreatic fat necrosis worsens acute pancreatitis independent of pancreatic necrosis via unsaturated fatty acids increased in human pancreatic necrosis collections [J]. Gut, 2016, 65(1): 100-111.
[41]	Durgampudi C, Noel P, Patel K, et al. Acute lipotoxicity regulates severity of biliary acute pancreatitis without affecting its initiation [J]. Am J Pathol, 2014, 184(6): 1773-1784.
[1]	Peery AF, Crockett SD, Murphy CC, et al. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the united states: update 2018 [J]. Gastroenterology, 2019, 156(1): 254.e11-272.e11.
[2]	Wu D, Tang M, Zhao Y, et al. Impact of seasons and festivals on the onset of acute pancreatitis in Shanghai, China [J]. Pancreas, 2017, 46(4): 496-503.
[3]	Forsmark Ch E, Vege SS, Wilcox CM. Acute Pancreatitis [J]. N Engl J Med, 2017, 376(6): 598-599.
[4]	Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus [J]. Gut, 2013, 62(1): 102-111.
[5]	Ogden CL, Carroll MD, Curtin LR, et al. Prevalence of overweight and obesity in the United States, 1999-2004 [J]. Jama, 2006, 295(13): 1549-1555.
[6]	Ogden CL, Carroll MD, Kit BK, et al. Prevalence of childhood and adult obesity in the United States, 2011-2012 [J]. Jama, 2014, 311(8): 806-814.
[7]	Finkelstein EA, Trogdon JG, Cohen JW, et al. Annual medical spending attributable to obesity: payer-and service-specific estimates [J]. Health Aff (Millwood), 2009, 28(5): w822-w831.
[8]	Wang Y, Beydoun MA, Liang L, et al. Will all Americans become overweight or obese? estimating the progression and cost of the US obesity epidemic [J]. Obesity (Silver Spring), 2008, 16(10): 2323-2330.
[9]	Curry SJ, Krist AH, Owens DK, et al. Behavioral weight loss interventions to prevent obesity-related morbidity and mortality in adults: US Preventive Services Task Force Recommendation Statement [J]. Jama, 2018, 320(11): 1163-1171.
[10]	Krishna SG, Hinton A, Oza V, et al. Morbid obesity is associated with adverse clinical outcomes in acute pancreatitis: a propensity-matched study [J]. Am J Gastroenterol, 2015, 110(11): 1608-1619.
[11]	Khatua B, El-Kurdi B, Singh VP. Obesity and pancreatitis [J]. Curr Opin Gastroenterol, 2017, 33(5): 374-382.
[12]	Radmard AR, Merat S, Kooraki S, et al. Gallstone disease and obesity: a population-based study on abdominal fat distribution and gender differences [J]. Ann Hepatol, 2015, 14(5): 702-709.
[13]	Flint R. Differences in acute general surgical admissions between obese or overweight patients compared to normal-sized patients [J]. N Z Med J, 2015, 128(1424): 35-41.
[14]	Lerch MM, Gorelick FS. Models of acute and chronic pancreatitis [J]. Gastroenterology, 2013, 144(6): 1180-1193.
[15]	Lee JY, Keane MG, Pereira S. Diagnosis and treatment of gallstone disease [J]. Practitioner, 2015, 259(1783): 15-19, 2.
[16]	Coban G, Yildirim E, Gokturk S, et al. Body mass index, cholecystitis, cholelithiasis, pancreatitis and imaging of common bile duct stones [J]. Am J Med Sci, 2014, 347(5): 364-369.
[17]	Pitha J, Kovar J, Blahova T. Fasting and nonfasting triglycerides in cardiovascular and other diseases [J]. Physiol Res, 2015, 64 (Suppl 3): S323-S330.
[18]	Vipperla K, Somerville C, Furlan A, et al. Clinical profile and natural course in a large cohort of patients with hypertriglyceridemia and pancreatitis [J]. J Clin Gastroenterol, 2017, 51(1): 77-85.
[19]	Shah AS, Wilson DP. Primary hypertriglyceridemia in children and adolescents [J]. J Clin Lipidol, 2015, 9(5 Suppl): S20-S28.
[20]	Blackett PR, Wilson DP, McNeal CJ. Secondary hypertriglyceridemia in children and adolescents [J]. J Clin Lipidol, 2015, 9(5 Suppl): S29-S40.
[21]	Albai O, Roman D, Frandes M. Hypertriglyceridemia, an important and independent risk factor for acute pancreatitis in patients with type 2 diabetes mellitus [J]. Ther Clin Risk Manag, 2017, 13: 515-522.
[22]	Monami M, Nreu B, Scatena A, et al. Safety issues with glucagon-like peptide-1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): Data from randomized controlled trials [J]. Diabetes Obes Metab, 2017, 19(9): 1233-1241.
[23]	Mondragon A, Davidsson D, Kyriakoudi S, et al. Divergent effects of liraglutide, exendin-4, and sitagliptin on beta-cell mass and indicators of pancreatitis in a mouse model of hyperglycaemia [J]. PLoS One, 2014, 9(8): e104873.
[24]	Kobayashi T, Manivel JC, Bellin MD, et al. Correlation of pancreatic histopathologic findings and islet yield in children with chronic pancreatitis undergoing total pancreatectomy and islet autotransplantation [J]. Pancreas, 2010, 39(1): 57-63.
[25]	Singh S, Chang HY, Richards TM, et al. Glucagonlike peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study [J]. JAMA Intern Med, 2013, 173(7): 534-539.
[26]	Rehman MB, Tudrej BV, Soustre J, et al. Efficacy and safety of DPP-4 inhibitors in patients with type 2 diabetes: Meta-analysis of placebo-controlled randomized clinical trials [J]. Diabetes Metab, 2017, 43(1): 48-58.
[27]	Liao KF, Lin CL, Lai SW, et al. Sitagliptin use and risk of acute pancreatitis in type 2 diabetes mellitus: A population-based case-control study in Taiwan [J]. Eur J Intern Med, 2016, 27: 76-79.
[28]	Storgaard H, Cold F, Gluud LL, et al. Glucagon-like peptide-1 receptor agonists and risk of acute pancreatitis in patients with type 2 diabetes [J]. Diabetes Obes Metab, 2017, 19(6): 906-908.
[29]	Chang J, Corcelles R, Boules M, et al. Predictive factors of biliary complications after bariatric surgery [J]. Surg Obes Relat Dis, 2016, 12(9): 1706-1710.
[30]	Kumaravel A, Zelisko A, Schauer P, et al. Acute pancreatitis in patients after bariatric surgery: incidence, outcomes, and risk factors [J]. Obes Surg, 2014, 24(12): 2025-2030.
[42]	Patel K, Trivedi RN, Durgampudi C, et al. Lipolysis of visceral adipocyte triglyceride by pancreatic lipases converts mild acute pancreatitis to severe pancreatitis independent of necrosis and inflammation [J]. Am J Pathol, 2015, 185(3): 808-819.
[43]	Choh AC, Demerath EW, Lee M, et al. Genetic analysis of self-reported physical activity and adiposity: the Southwest Ohio Family Study [J]. Public Health Nutr, 2009, 12(8): 1052-1060.
[31]	Arapis K, Tammaro P, Goujon G, et al. Elevated plasma pancreatic enzyme concentrations after Roux-en-Y gastric bypass may indicate closed loop obstruction [J]. Ann R Coll Surg Engl, 2017, 99(2): e62-e64.
[32]	Unal B, Uzun OC, Bassorgun CI, et al. A rare complication of gastric bypass (weight loss) surgery: nesidioblastosis [J]. Int J Surg Pathol, 2015, 23(1): 68-70.

Please choose a citation manager

Content to export